JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SANDERS-BUSH, E.
Right arrow Articles by SULSER, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SANDERS-BUSH, E.
Right arrow Articles by SULSER, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-PHENYLALANINE
*(L)-TRYPTOPHAN
*5-HYDROXYTRYPTOPHAN
*AMPHETAMINE
*CHLORINE
*PROBENECID
*RESERPINE
*TRITIUM
Journal of Pharmacology And Experimental Therapeutics, Vol. 175, Issue 2, 419-426, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


p-CHLOROAMPHETAMINE: IN VIVO INVESTIGATIONS ON THE MECHANISM OF ACTION OF THE SELECTIVE DEPLETION OF CEREBRAL SEROTONIN

E. SANDERS-BUSH 1 and F. SULSER 1

1 Psychopharmacology Research Center, Department of Pharmacology, Vanderbilt, University School of Medicine, Nashville, Tennessee

The present investigations were undertaken to study the mechanism by which p-chloramphetamine decreases both serotonin (5-HT) and 5-hydroxyindole acetic acid in the brains of rats. 1) Doses of p-chloroamphetamine, which markedly reduced the level of endogenous 5-HT in brain, failed to decrease labeled 5-HT derived from either intraventricularly administered 5-HT-H3 or 5-hydroxytryptophan-C14. Under similar conditions, reserpine and RO 4-1284 caused a striking reduction of both the endogenous and the labeled 5-HT. 2) p-Chloroamphetamine partially blocked the increase of endogenous brain 5-HT but not that of brain norepinephrine, after monoamine oxidase inhibition by pargyline. 3) The increase in brain 5-hydroxyindole acetic acid resulting from the administration of probenecid was almost completely blocked in animals treated 48 and 24 hours previously with p-chloroamphetamine. This blockade was not evident when p-chloroamphetamine was administered 10 minutes prior to probenecid. 4) Like p-chlorophenylaline, p-chloroamphetamine caused a decrease in the amount of 5-HT-C14 in brain formed from intraventricularly administered tryptophan-C14; however, it did not change the amount of 5-HT-C14 derived from intraventricular 5-hydroxytryptophan-C14 5) p-Chloroamphetamine did not alter the level of either endogenous tryptophan or tryptophan-C14 taken up into the brain from the ventricular system. On the basis of these experimental data, it is concluded that p-chloroamphetamine impairs the synthesis of cerebral 5-HT. Moreover, the results of these studies in vivo implicate an inhibition of cerebral tryptophan hydroxylase in the simultaneous lowering of cerebral 5-HT and 5-hydroxyindole acetic acid by p-chloroamphetamine.

Submitted on January 19, 1970
Accepted on July 12, 1970




This article has been cited by other articles:


Home page
JAMAHome page
G. A. Ricaurte, L. S. Forno, M. A. Wilson, L. E. DeLanney, I. Irwin, M. E. Molliver, and J. W. Langston
({+/-}3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates
JAMA, July 1, 1988; 260(1): 51 - 55.
[Abstract] [PDF]


Home page
ScienceHome page
J. Harvey, S. McMaster, and L. Yunger
P-Chloramphetamine: Selective neurotoxic action in brain
Science, March 7, 1975; 187(4179): 841 - 843.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.